Latest News
- EU regulators recommend approval of infusion therapy for pediatric MS
- FDA grants priority review to oral fenebrutinib for RMS and PPMS
- New MRI test speeds up MS diagnosis and avoids painful lumbar punctures
- Viral infections may accelerate ALS progression, study finds
- Stroke rates nearly double among younger adults over three decades
- Rapid blood test for stroke receives CE mark
- New metagenomic approach aims to improve detection of meningitis and encephalitis infections
- Transient ischaemic attack associated with increased risk of dementia
- FDA approves tavapadon for Parkinson’s disease
- NHS pilots rapid genomic test to transform brain tumour diagnosis
Categories
- ABN (1)
- ACNR News (14)
- Acquired Brain Injury (23)
- Alzheimer's Disease (72)
- Amyotrophic Lateral Sclerosis (ALS) (10)
- Artificial Intelligence (15)
- Australia/New Zealand (1)
- Awards & Appointments (16)
- Book Reviews (2)
- Brain Mapping (3)
- Brain tumours (6)
- Case Reports (10)
- Charcot-Marie-Tooth Disease (1)
- Charity (9)
- Cognition (3)
- Courses & Conferences (5)
- COVID-19 Articles (4)
- Dementia (53)
- Digital Health (3)
- Encephalitis (3)
- Epilepsy (31)
- Genetics (4)
- Guidelines (1)
- Headache (25)
- Hereditary Spastic Paraplegia (1)
- Huntington's disease (12)
- Industry News (258)
- Major Depressive Disorder (3)
- Movement Disorders (39)
- Multiple Sclerosis (73)
- Myasthenia Gravis (13)
- Neuro oncology (1)
- Neurodegenerative diseases (8)
- Neurodevelopmental disorders (4)
- Neuroimmunology (3)
- Neurology News (39)
- Neuromuscular (16)
- Neuromyelitis optica spectrum disorders (1)
- Neuropsychiatry (2)
- Neurosurgery (3)
- NHS News (2)
- Online First (14)
- Optic neuritis (1)
- Paedatric Neurology (2)
- Pain (5)
- Parkinson’s Disease (60)
- Rehabilitation (16)
- Rehabilitation Articles (4)
- Research (30)
- RLS (2)
- Sleep (10)
- Special Feature (1)
- Spinal muscular atrophy (4)
- Sponsored Feature (7)
- Stroke (20)
- Syncope (1)
- Tourette Syndrome (1)
- Uncategorised (41)
- Uncategorized (12)


